The Calmer Co. International Limited has revised the schedule for its renounceable entitlement offer aimed at raising up to A$3.5 million, with key dates stretching from late July to late August 2026.
- Revised timetable for pro-rata renounceable entitlement offer
- Offer to raise up to A$3.5 million
- Rights trading from 30 July to 12 August 2026
- Closing date set for 19 August 2026, subject to extension
- New shares and options trading to commence 27 August 2026
Revised Timetable for $3.5 Million Capital Raise
The Calmer Co. International Limited (ASX:CCO) has updated the timeline for its renounceable entitlement offer, which targets raising up to A$3.5 million. The revised schedule spans from the initial announcement on 27 July 2026 through to the expected commencement of trading in new shares and options on 27 August 2026.
The offer allows eligible shareholders to subscribe for one new share for every existing share held, with rights trading starting on 30 July and closing on 12 August. The closing date for acceptances is set for 19 August, although the company retains discretion to extend this deadline.
Offer Mechanics and Market Impact
Following the close of the offer, The Calmer Co. will issue new shares and options, with trading expected to begin on 27 August. This capital raising effort is part of the company’s broader strategy to fund debt repayment, inventory expansion, and marketing initiatives, as outlined in its earlier announcement.
Eligible shareholders in Australia, New Zealand, Fiji, and the United States can participate, reflecting the company's international footprint across these key markets. The entitlement offer includes free attaching options exercisable at $0.002, adding potential upside for investors.
Strategic Positioning Amid Growth Initiatives
The timing of this entitlement offer aligns with The Calmer Co.’s recent operational milestones, including securing Coles ranging for its Fiji Kava FZZR product and expanding its US retail presence. The capital raise aims to support these growth initiatives and underpin the company's ongoing market expansion efforts.
While the timetable is indicative and subject to change, the updated dates provide clarity for investors monitoring the company’s funding progress and potential dilution impact.
Bottom Line?
Investors should watch for the final results of the entitlement offer and any extension announcements that could affect timing and capital structure.
Questions in the middle?
- Will the entitlement offer fully subscribe to the targeted A$3.5 million?
- How will the new capital influence The Calmer Co.’s expansion in the US and Australian markets?
- What impact will the free attaching options have on shareholder value over the next 2.5 years?